SPRINT: Celebrating Benefits for Older Patients
SOURCE: Williamson JD, Supiano MA, Applegate WB, et al. Intensive vs standard blood pressure control and cardiovascular disease outcomes in adults aged ≥ 75 years: A randomized clinical trial. JAMA 2016;315:2673-2682.
Hypertension experts and generalists alike consider the Systolic Blood Pressure Intervention Trial (SPRINT) a game changer. Despite the advice from Eighth Joint National Committee that lowering blood pressure to < 140/90 mmHg was sufficient for most non-senior adults, the question of whether lower is better was never believed to have been adequately clarified. SPRINT determined that aiming for a systolic blood pressure of < 120 mmHg provided significant reductions in cardiovascular and all-cause mortality compared to “traditional” blood pressure goals (< 140 mmHg systolic blood pressure) in hypertensive non-diabetic adults. SPRINT also was large enough (n = 9,361) and included a sufficient number of patients > 75 years of age (n = 2,636) to make meaningful commentary about benefits in that specific age demographic.
After a median of 3.14 years follow-up in patients > 75 years of age (mean age = 80 years), major adverse cardiovascular events fell by approximately one-third in the intensively treated group, as was all-cause mortality, without incurring excess serious adverse events.
SPRINT is not the first clinical trial to confirm benefits of treating hypertension in super-seniors: the Hypertension in the Very Elderly Trial (HYVET; mean age = 83 years) ended early due to the important mortality reductions observed in treated seniors attributable to blood pressure control. Using available knowledge, age should not be considered a barrier to seeking good blood pressure control.
Using available knowledge, age should not be considered a barrier to seeking good blood pressure control.
Subscribe Now for Access
You have reached your article limit for the month. We hope you found our articles both enjoyable and insightful. For information on new subscriptions, product trials, alternative billing arrangements or group and site discounts please call 800-688-2421. We look forward to having you as a long-term member of the Relias Media community.